/Companies

Rayze Bio

San Diego, US · Founded 2020 · Delaware corporation · 283 employees on LinkedIn · 11 known investors

Find your way into Rayze Bio

Sign up to see every warm intro you have to Rayze Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rayze Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.

Founders & leadership

Rayze Bio was founded in 2020 by Ken Song.

KSKen Song
Ken SongFounderKen Song is co-founder and former president and CEO of RayzeBio, a radiopharmaceutical company he led from its 2020 founding through its acquisition by Bristol Myers Squibb in 2023 for $4.1 billion. He previously co-founded and led Ariosa Diagnostics through its commercialization and 2015 acquisition by Roche, and trained in internal medicine and gastroenterology at UCSF and University of Washington respectively.
BHBen Hickey
Ben HickeyPresident
AB
Abhi Bhat, PhDSenior Vice President, Research & Development
DC
Deborah CharychNamed on SEC filing
YL
Yi LarsonNamed on SEC filing

Board

ARAaron Royston
Aaron RoystonBoard of Directors2020–2023Managing Partner at venBio Partners
JDJerel Davis
Jerel DavisBoard Member2020–2023Managing Director at Versant Ventures
BK
Bong KohBoard director
AKAaron Kantoff
Aaron KantoffFounding Board Member2020–2024Managing Partner at Scion Life Sciences

Investors · 11

Reported raises · per SEC filings

Form D private placements

$396.4M disclosed across 4 rounds · 2020–2022

▶$167.9MraisedSep 2022 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron KantoffDirector
  • Angie YouDirector
  • Aaron RoystonDirector
  • Yi LarsonDirector
  • Aubrey HaddachExecutive Officer
  • Mary TagliaferriDirector
  • Jerel DavisDirector
  • Ken SongExecutive Officer, Director
  • Arvind KushExecutive Officer
  • Maha KatabiDirector
  • Alex RosenDirector
Offering amount
$167.9M
Amount sold
$167.9M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$108.5MraisedJun 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Deborah CharychExecutive Officer
  • Aaron RoystonDirector
  • Jerel DavisDirector
  • Ken SongExecutive Officer, Director
  • Bong KohDirector
  • Aaron KantoffDirector
  • Yi LarsonDirector
Offering amount
$108.5M
Amount sold
$108.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$105MraisedDec 2020 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bong KohDirector
  • Ken SongExecutive Officer, Director
  • Aaron KantoffDirector
  • Jerel DavisDirector
  • Aaron RoystonDirector
Offering amount
$105M
Amount sold
$105M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedNov 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron RoystonDirector
  • Jerel DavisDirector
  • Aaron KantoffDirector
  • Ken SongExecutive Officer, Director
Offering amount
$45M
Amount sold
$15M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Rayze Bio went on to found or lead other companies.

Related companies · 1

Companies working in the same space as Rayze Bio.

Frequently asked questions

What does Rayze Bio do?
RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.
Who founded Rayze Bio?
Rayze Bio was founded by Ken Song in 2020.
Who are Rayze Bio's investors?
Rayze Bio's investors include LifeSci Venture Partners, Samsara BioCapital, Scion Life Sciences, Sofinnova Ventures, TCG Crossover, venBio Partners, Versant Ventures, Viking Global and 3 more.
How much funding has Rayze Bio raised?
Rayze Bio has disclosed $396.4M raised across 4 rounds.
Where is Rayze Bio headquartered?
Rayze Bio is headquartered in San Diego, US.